DrugPatentWatch Database Preview
Organon Usa Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?
ORGANON USA INC has twenty-four approved drugs.
There are three US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.
There are seventy-nine patent family members on ORGANON USA INC drugs in thirty-two countries and twenty-three supplementary protection certificates in nine countries.
Summary for Organon Usa Inc
| International Patents: | 79 |
| US Patents: | 3 |
| Tradenames: | 27 |
| Ingredients: | 22 |
| NDAs: | 24 |
| Patent Litigation for Organon Usa Inc: | See patent lawsuits for Organon Usa Inc |
Drugs and US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | WIGRAINE | caffeine; ergotamine tartrate | TABLET;ORAL | 086562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | DESOGEN | desogestrel; ethinyl estradiol | TABLET;ORAL-21 | 020071-001 | Dec 10, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-002 | Jan 12, 2001 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-001 | Jan 12, 2001 | 5,178,878 | Start Trial |
| Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | 5,418,226 | Start Trial |
| Organon Usa Inc | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | 5,150,718 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Organon Usa Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2007008881 | Start Trial |
| Israel | 184586 | Start Trial |
| China | 101141994 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Organon Usa Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0277829 | C300016 | Netherlands | Start Trial | PRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517 |
| 1453521 | 122015000093 | Germany | Start Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
| 1380301 | CA 2009 00017 | Denmark | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
